Next Financial Group’s VanEck Biotech ETF BBH Stock Holding History

Next Financial Group’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$14K	Hold	75	–	–	﹤0.01%	2030
2021 Q3	$15K	Hold	75	–	–	﹤0.01%	1890
2021 Q2	$15K	Hold	75	–	–	﹤0.01%	1843
2021 Q1	$13K	Hold	75	–	–	﹤0.01%	1785
2020 Q4	$13K	Hold	75	–	–	﹤0.01%	1679
2020 Q3	$12K	Buy	+75	New	+$12.2K	﹤0.01%	1565
2020 Q2	–	Sell	-75	Closed	-$10K	–	709
2020 Q1	$10K	Hold	75	–	–	﹤0.01%	1516
2019 Q4	$10K	Buy	+75	New	+$9.86K	﹤0.01%	1757
2017 Q3	–	Sell	-100	Closed	-$13K	–	1754
2017 Q2	$13K	Buy	+100	New	+$12.1K	﹤0.01%	1218
2017 Q1	–	Sell	-175	Closed	-$19K	–	1897
2016 Q4	$19K	Hold	175	–	–	﹤0.01%	1378
2016 Q3	$20K	Buy	+175	New	+$19.9K	﹤0.01%	1353
2014 Q4	–	Sell	-75	Closed	-$8K	–	1915
2014 Q3	$8K	Buy	+75	New	+$7.59K	﹤0.01%	1854

Other funds holding BBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

MJRIC

Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return

MCM

Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return

KAS

Kestra Advisory Services Austin, Texas $26.4B AUM 21.05% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Next Financial Group's BBH Position: Q4 2021 in Review

Next Financial Group held its VanEck Biotech ETF (BBH) position steady in Q4 2021 at 75 shares worth $14K. The position accounts for ﹤0.01% of the portfolio, ranked #2030.

Next Financial Group first reported a position in BBH in Q3 2014 and has held it in 12 quarters since. The position peaked at $20K in Q3 2016. 126 funds tracked by Wall St. Rank hold BBH as of Q4 2021.

Next Financial Group held 75 shares of VanEck Biotech ETF worth $14K as of Q4 2021.
Next Financial Group left its VanEck Biotech ETF share count unchanged in Q4 2021.
VanEck Biotech ETF made up ﹤0.01% of Next Financial Group's portfolio in Q4 2021, its #2030 holding.
Next Financial Group first reported a position in VanEck Biotech ETF in Q3 2014 and has held it in 12 quarters since.
Next Financial Group's VanEck Biotech ETF position peaked at $20K in Q3 2016.
126 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q4 2021.

Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.